Long-Term Outcomes of GLP-1 Therapies in Type 1 Diabetes
Use of GLP-1 receptor agonists—with or without glucose-dependent insulinotropic polypeptide (GIP)—may be associated with improved clinical outcomes in…
Browsing Category